Influenza virus neuraminidase contributes to secondary bacterial pneumonia.

Cited by (219)

Items 101–200 of 219

1. Probiotics as a biotherapeutics for the management and prevention of respiratory tract diseases
   Nabendu Debnath, Ashwani Kumar, Ashok Kumar Yadav · 2022 · Microbiology and Immunology
2. The personal touch: strategies toward personalized vaccines and predicting immune responses to them
   Richard B. Kennedy, Inna G. Ovsyannikova, Nathaniel Dane Lambert, Iana H. Haralambieva, Gregory A. Poland · 2014 · Expert Review of Vaccines
3. How influenza’s neuraminidase promotes virulence and creates localized lung mucosa immunodeficiency
   Ajay Bhatia, Richard Eric Kast · 2006 · Cellular & Molecular Biology Letters
4. Re-understanding anti-influenza strategy: attach equal importance to antiviral and anti-inflammatory therapies
   Zhengtu Li, Li Li, Shuai Zhao, Jing Li, Hongxia Zhou, Yunhui Zhang, Zifeng Yang, Bing Yuan · 2018 · Journal of Thoracic Disease
5. The complication of coinfection.
   Lesley Pasman · 2012 · Europe PMC (PubMed Central)
6. Respiratory viral and pneumococcal coinfection of the respiratory tract: implications of pneumococcal vaccination
   David Paul Moore, Ron Dagan, Shabir Ahmed Madhi · 2012 · Expert Review of Respiratory Medicine
7. The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly
   Susanne M. Huijts, Frank E. J. Coenjaerts, Marieke Bolkenbaas, Cornelis H. van Werkhoven, Diederick E. Grobbee, Marc J. M. Bonten · 2017 · Clinical Microbiology and Infection
8. Aetiology of community-acquired pneumonia in hospitalized adult patients in New Caledonia
   Sylvain Mermond, Alain Berlioz-Arthaud, Maurice Estivals, Francine Baumann, H. Lévénès, Paul M. V. Martin · 2010 · Tropical Medicine & International Health
9. Influenza vaccines to control influenza-associated bacterial infection: where do we stand?
   Ioanna Christopoulou, Kenny Roose, Lorena Itatí Ibañez, Xavier Saelens · 2014 · Expert Review of Vaccines
10. Influenza virus and pneumococcal neuraminidases enhance catalysis by similar yet distinct sialic acid–binding strategies
    Laura Klenow, Rageia Elfageih, Jin Gao, Hongquan Wan, Stephen G. Withers, Jan‐Willem De Gier, Robert Daniels · 2023 · Journal of Biological Chemistry
11. The Thousand Faces of Invasive Group A Streptococcal Infections: Update on Epidemiology, Symptoms, and Therapy
    Stefania Mercadante, Andrea Ficari, Lorenza Romani, Maia De Luca, Costanza Tripiciano, Sara Chiurchiù, Francesca Ippolita Calò Carducci, Laura Cursi, Martina Di Giuseppe, Andrzej Krzysztofiak et al. · 2024 · Children
12. Deletions in the Neuraminidase Stalk Region of H2N2 and H9N2 Avian Influenza Virus Subtypes Do Not Affect Postinfluenza Secondary Bacterial Pneumonia
    Ashok Chockalingam, Danielle Hickman, Lindomar Pena, Jianqiang Ye, Andrea Ferrero, José Echenique, Hongjun Chen, Troy C. Sutton, Daniel Roberto Perez · 2012 · Journal of Virology
13. Influenza infection directly alters innate IL-23 and IL-12p70 and subsequent IL-17A and IFN-γ responses to pneumococcus in vitro in human monocytes
    Sinéad T. Loughran, Patrick Power, Paula T. Maguire, S. McQuaid, Paul Buchanan, Ingileif Jónsdóttir, Robert W. Newman, Ruth Harvey, PATRICIA A. JOHNSON · 2018 · PLoS ONE
14. Differential expression and correlation analysis of miRNA–mRNA profiles in swine testicular cells infected with porcine epidemic diarrhea virus
    Xiaoqian Zhang, Chang Li, Bingzhou Zhang, Zhonghua Li, Wei Zeng, Rui Luo, Jiyue Cao, Guofu Cheng, Shengxian Fan, Qigai He · 2021 · Scientific Reports
15. Can group A streptococcus infections be influenced by viruses in the respiratory tract?
    Claire E. Turner · 2022 · The Lancet Infectious Diseases
16. Influenza-associated bacterial pneumonia; managing and controlling infection on two fronts
    Aaron J. Campigotto, Samira Mubareka · 2014 · Expert Review of Anti-infective Therapy
17. Neutrophil and monocyte receptor expression in uncomplicated and complicated influenza A infection with pneumonia
    Karlis Pauksens, Gustav Fjaertoft, Lena Håkansson, Per Venge · 2008 · Scandinavian Journal of Infectious Diseases
18. Respiratory exposure to 6PPD-quinone aggravates Klebsiella pneumoniae pneumonia by impairing the innate immune function of alveolar macrophages
    Xia-Wen Qiu, Wenting Zhang, Xuefei Chen, Guofu Luo, Xiaoyan Qi, Qiaoqi Guo, Xinyan Zhou, Xinhai Sun, Hai Xiang, Huajun Feng et al. · 2025 · Journal of Hazardous Materials
19. Outbreak of influenza A and B among military recruits: evidence from viral culture and polymerase chain reaction.
    Po‐Yu Liu, Li-Chung Wang, Yu‐Hui Lin, Che-An Tsai, Zhi‐Yuan Shi · 2009 · PubMed
20. Expression and DNA Microarray Analysis of a Platelet Activating Factor-Related Molecule in Severe Pneumonia in Mice Due to Influenza Virus and Bacterial Co-Infection
    Masafumi Seki, Kosuke Kosai, Atsuko Hara, Yoshifumi Imamura, Shigeki Nakamura, Shintaro Kurihara, Koichi Izumikawa, Hiroshi Kakeya, Yoshihiro Yamamoto, Katsunori Yanagihara et al. · 2009 · Japanese Journal of Infectious Diseases
21. Neutrophil extracellular traps mediate severe lung injury induced by influenza A virus H1N1 in mice coinfected with Staphylococcus aureus
    Tong Yi, Wenxin Ding, Yuanzhen Hao, Lifeng Cen, Jiyang Li, Xunlong Shi, Ting Wang, Daofeng Chen, Haiyan Zhu · 2022 · Microbial Pathogenesis
22. Passive Immune Neutralization Strategies for Prevention and Control of Influenza A Infections
    Jianqiang Ye, Hongxia Shao, Daniel Roberto Perez · 2012 · Immunotherapy
23. Proteomic Analysis of IPEC‐J2 Cells in Response to Coinfection by Porcine Transmissible Gastroenteritis Virus and Enterotoxigenic Escherichia coli K88
    L. Xia, Lei Dai, Liqi Zhu, W. Hu, Qian Yang · 2017 · PROTEOMICS - Clinical Applications
24. The Contribution of Viral Proteins to the Synergy of Influenza and Bacterial Co-Infection
    Miriam Mikušová, Karolína Tomčíková, Katarína Briestenská, František Kostolanský, Eva Varečková · 2022 · Viruses
25. Invasive bacterial infections following influenza: a time‐series analysis in Montréal, Canada, 1996–2008
    R. Allard, Michel Couillard, Pierre A. Pilon, M. Kafka, Lucie Bédard · 2011 · Influenza and Other Respiratory Viruses
26. VII International Symposium on Respiratory Viral Infections
    Alison Bermingham, Kelly J. Henrickson, Frederick G. Hayden, Maria Cristina Fleischmann Alves Zambon · 2007 · Antiviral Therapy
27. The Effect of Intravenous Peramivir, Compared with Oral Oseltamivir, on the Outcome of Post-Influenza Pneumococcal Pneumonia in Mice
    Akitaka Tanaka, Shigeki Nakamura, Masafumi Seki, Naoki Iwanaga, Toshiki Kajihara, Mitsutaka Kitano, Tomoyuki Homma, Shintaro Kurihara, Yoshifumi Imamura, Taiga Miyazaki et al. · 2014 · Antiviral Therapy
28. Development of secondary bacterial pneumonia in adults presenting with influenza versus noninfluenza viral respiratory infection
    Kathryn H. Melamed, Justin Williams, Xiaoyan Wang, Scott B. Hu, Christopher D. Nguyen, Jing Cui, Jane C. Deng · 2020 · Therapeutic Advances in Respiratory Disease
29. Increased Rates of Intense Nasopharyngeal Bacterial Colonization of Vietnamese Children with Radiological Pneumonia
    Đặng Đức Anh, Phan Le Thanh Huong, Kiwao Watanabe, Nguyen Thu Nguyet, Nguyen Thu Hien Anh, Ngo Thi Thi, Nguyễn Tiến Dũng, Doan Mai Phuong, Susumu Tanimura, Yasushi Ohkusa et al. · 2007 · The Tohoku Journal of Experimental Medicine
30. Interaction between influenza virus andStreptococcus pneumoniaein severe pneumonia
    Shabir Ahmed Madhi, Barry D. Schoub, Keith P. Klugman · 2008 · Expert Review of Respiratory Medicine
31. Concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza
    Hong Zhang · 2008 · Journal of Antimicrobial Chemotherapy
32. Influenza in hospitalised patients with malignancy: a propensity score matching analysis
    Jiarui Li, Dingding Zhang, Zhao Sun, Chunmei Bai, Lin Zhao · 2020 · ESMO Open
33. Contributions of Influenza Virus Hemagglutinin and Host Immune Responses Toward the Severity of Influenza Virus: Streptococcus pyogenes Superinfections
    Joshua M. Klonoski, Trevor Watson, Thomas E. Bickett, Joshua M. Svendsen, Tonia J. Gau, Alexandra Britt, Jeff T. Nelson, Evelyn Heymann Schlenker, Michael S. Chaussee, Agnieszka Rynda‐Apple et al. · 2018 · Viral Immunology
34. Immunotherapy with a Combination of Intravenous Immune Globulin and P4 Peptide Rescues Mice from Postinfluenza Pneumococcal Pneumonia
    Jenni N Weeks, Kelli Lynn Boyd, Gowrisankar Rajam, Edwin W. Ades, Jonathan A. McCullers · 2011 · Antimicrobial Agents and Chemotherapy
35. Quantitative detection of Staphylococcus aureus, Streptococcus pneumoniae and Haemophilus influenzae in patients with new influenza A (H1N1)/2009 and influenza A/2010 virus infection
    Safaeyan, Firouzeh, Nahaei, Mohammad Reza, Seifi, Sirus Jedary, Kafil, Hossein Samadi, Sadeghi, Javid · 2015 · German Medical Science GMS Publishing House
36. ¿Por qué hay más empiemas pediátricos en España?
    Federico Martinón‐Torres, E. Bernaola Iturbe, F. Giménez Sánchez, M. Baca Cots, F. de Juan Martín, Javier Díez‐Domingo, María Garcés‐Sánchez, José Antonio Gómez Campderá, J.J. Picazo, Valentín Pineda Solas · 2008 · Anales de Pediatría
37. The Streptococcus pyogenes fibronectin/tenascin-binding protein PrtF.2 contributes to virulence in an influenza superinfection
    Andrea L. Herrera, Haddy Faal, Danielle Moss, Leslie A. Addengast, Lauren Fanta, Kathleen M. Eyster, Victor C. Huber, Michael S. Chaussee · 2018 · Scientific Reports
38. Impact of HIV on the severity of influenza
    Daniel Alberto González Álvarez, Luis Fernando López-Cortés, Elisa Cordero · 2016 · Expert Review of Respiratory Medicine
39. 16HBE Cell Lipid Mediator Responses to Mono and Co-Infections with Respiratory Pathogens
    Daniel Schultz, Surabhi Surabhi, Nicolas Stelling, Michael Rothe, KoInfekt Study Group, Karen Methling, Sven Hammerschmidt, Nikolai Siemens, Michael Lalk · 2020 · Metabolites
40. Bacterial Superinfection Following Lung Inflammatory Disorders
    Maryam Habibzay, Gudrun Weiss, Tracy Hussell · 2013 · Future Microbiology
41. Respiratory Viruses
    Christine C. Robinson · 2009 · Wiley eBooks
42. Inhibiting influenza virus transmission using a broadly acting neuraminidase that targets host sialic acids in the upper respiratory tract
    Mila Brum Ortigoza, Catherina L. Mobini, Hedy L. Rocha, Stacey Bartlett, Cynthia A. Loomis, Jeffrey N. Weiser · 2024 · mBio
43. Respiratory Viruses and Cystic Fibrosis
    Kate Brackenborough, Huw Ellis, William George Flight · 2022 · Seminars in Respiratory and Critical Care Medicine
44. Sialic Acids in Health and Disease
    Gerardo N. Guerrero-Flores, Fayth M Butler, Verónica Lucrecia Martínez Marignac, Guangyu Zhang, Fabio J. Pacheco, Danilo S. Boskovic · 2025 · Biologics
45. Recent Advances in the Diagnosis and Treatment of Influenza Pneumonia
    Lucía Marzoratti, Hernán A. Iannella, Victoria Fernández Gómez, Sandra B. Figueroa · 2012 · Current Infectious Disease Reports
46. Clinical differences between respiratory viral and bacterial mono‐ and dual pathogen detected among S ingapore military servicemen with febrile respiratory illness
    Zheng Jie Marc Ho, Xiahong Zhao, Alex Richard Cook, Jin Phang Loh, Sock Hoon Ng, Boon Huan Tan, Vernon J. Lee · 2015 · Influenza and Other Respiratory Viruses
47. Clinical and inflammatory response to antiviral treatments in dogs with parvoviral enteritis
    Nergis Ulaş, Yunusemre Özkanlar, Seçkin Özkanlar, Mehmet Özkan Timurkan, Hakan Aydın · 2023 · Journal of Veterinary Science
48. Influenza Virus: The Biology of a Changing Virus
    Samira Mubareka, Peter Palese · 2010 · Springer eBooks
49. Dynamic Pneumococcal Genetic Adaptations Support Bacterial Growth and Inflammation during Coinfection with Influenza
    Amanda Pfaff Smith, Lindey C. Lane, Tim van Opijnen, Stacie Woolard, Robert Carter, Amy Iverson, Corinna Burnham, Peter Vogel, Dana Roeber, Gabrielle M. Hochu et al. · 2021 · Infection and Immunity
50. Effect of pharynx epithelial cells surface desialylation on receptor-mediated adherence ofStaphylococcus aureus
    Serhan Sakarya, Bülent Ertuğrul, T. Öztürk, Cengiz Gökbulut · 2009 · Journal of Applied Microbiology
51. Pre-Clinical Evaluation of the Antiviral Activity of Epigalocatechin-3-Gallate, a Component of Green Tea, against Influenza A(H1N1)pdm Viruses
    Harry L. Stannard, Paulina Koszalka, Nikita Deshpande, Yves Desjardins, Mariana Baz · 2023 · Viruses
52. Épidémiologie microbienne des infections respiratoires basses actualités
    F. Trémolières · 2006 · Médecine et Maladies Infectieuses
53. Mixed community-acquired lower respiratory tract infections
    Paolo Tarsia, Stefano Aliberti, Maria Pappalettera, Francesco Blasi · 2007 · Current Infectious Disease Reports
54. Mechanisms of Predisposition to Pneumonia
    Anthony J. Infante, Jonathan A. McCullers, Carlos Javier Orihuela · 2015 · Elsevier eBooks
55. Understanding the Molecular Interactions Between Influenza A Virus and Streptococcus Proteins in Co-Infection: A Scoping Review
    Askar K. Alshammari, Meshach Maina, Adam Mark Blanchard, Janet M. Daly, Stephen P. Dunham · 2025 · Pathogens
56. Respiratory bacterial and viral pathogen spectrum among influenza-positive and influenza-negative patients
    Jing Hong Shi, Shi Han, Yating Zhang, Xiaohua Lu, Yunxia Gan, Narenqimuge Tong, Lu Ma, Hang Zhuan, Ying Dai, Yaqi Ji et al. · 2025 · BMC Infectious Diseases
57. The W-Shaped Mortality-Age Distribution of Novel H1N1 Influenza Virus Helps Reconstruct the Second Wave of Pandemic 1918 Spanish Flu
    Lai KY Wing Yiu · 2015 · Journal of Pulmonary & Respiratory Medicine
58. Impact of Influenza on Pneumococcal Vaccine Effectiveness during Streptococcus pneumoniae Infection in Aged Murine Lung
    Ermias Jirru, Stefi F. Lee, Rebecca M. Harris, Jianjun Yang, Soo Jung Cho, Heather W. Stout-Delgado · 2020 · Vaccines
59. Complicated features in a young child with influenza B virus pneumonia and co-infection withStenotrophomonas maltophilia
    S-H Chen, I‐Anne Huang, C‐T Wu, S-H Hsia, P-C Hung, CH Chiu · 2011 · Annals of Tropical Paediatrics
60. The Threat of Pandemic Influenza: Why Today is Not 1918
    Gregory D. Koblentz · 2009 · World Medical & Health Policy
61. Otolaryngological Complications in Patients Infected with the Influenza A (H1N1) Virus
    Catalina Gutierrez, Gonzalo Nazar, Juan Pablo Torres · 2011 · Otolaryngology
62. Morbidity of influenza, other acute respiratory viral infections and pneumonia in population of the Central district of Moscow, 2012 – 2016, and vaccine prevention
    Olga A. Gruzdeva, Т. Н. Биличенко, V.A. Vorontsova, A. V. Uvarova · 2018 · PULMONOLOGIYA
63. The Role of Punctuated Evolution in the Pathogenicity of Influenza Viruses
    Jonathan A. McCullers · 2016 · Microbiology Spectrum
64. Streptococcus pneumoniae: Invasion and Inflammation
    Allister J. Loughran, Carlos Javier Orihuela, ELAINE I. TUOMANEN · 2019 · ASM Press eBooks
65. Achievement of Healthy People 2010 Objective for Adult Pneumococcal Vaccination in an American Indian Community
    Marc S. Traeger, Kenneth R. Say, Verna Hastings, David A. Yost · 2010 · Public Health Reports
66. Growth activation of influenza virus by trypsin and effect of T-705 (favipiravir) on trypsin-optimized growth condition
    Tohru Daikoku, Tomoko Okuda, Makoto Kawai, Naoko I. MORITA, Toshitake Tanaka, Masaya Takemoto, Y. FUKUDA, Kouki Takahashi, N. NOMURA, Kazuko Shiraki · 2019 · Acta Virologica
67. The impact of vaccination against influenza and pneumococcal infection on the incidence of acute respiratory viral infections and community-acquired pneumonia in the Central Administrative District of Moscow
    O. A. Gruzdeva, Т. Н. Биличенко, M. A. Baryshev, A. V. Zhukova · 2021 · Epidemiology and Vaccinal Prevention
68. Infection with different human influenza A subtypes affects the period of susceptibility to secondary bacterial infections in ferrets
    Edin Jessica Mifsud, Rubaiyea Farrukee, Aeron C. Hurt, Patrick C. Reading, Ian Barr · 2022 · FEMS Microbes
69. Pyrrolo[2,3- e ]indazole as a novel chemotype for both influenza A virus and pneumococcal neuraminidase inhibitors
    Anna Egorova, Martina Richter, Maria G. Khrenova, Elisabeth Dietrich, Andrey M. Tsedilin, Elena Kazakova, Alexander Lepioshkin, Birgit Jahn, Vladimir V. Chernyshev, Michaela Schmidtke et al. · 2023 · RSC Advances
70. GRİP VE AŞI
    Sedat Kaygusuz, Serdar Gül · 2018 · Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
71. Respiratory Viral and Bacterial Superinfection
    Nima Naghshtabrizi, Keven Mara Robinson · 2026 · Clinics in Chest Medicine
72. Current insights into bacterial secondary infection following influenza A virus infection
    Jeong-Hoo Seo, Ye-Ji Seo, Hong‐Yeoul Ryu, Minsang Shin, Chung-Young Lee · 2026 · Frontiers in Microbiology
73. Expression of TMPRSS2 is up-regulated by bacterial flagellin, LPS, and Pam3Cys in human airway cells
    Marie Schwerdtner, Annika Skalik, Hannah Limburg, Jeff Bierwagen, Anna Lena Jung, Jens Dorna, Andreas Martin Kaufmann, Stefan Bauer, Bernd Schmeck, Eva Böttcher‐Friebertshäuser · 2023 · Life Science Alliance
74. Infections respiratoires à staphylocoques
    Groupe ECRIR · 2007 · Revue de Pneumologie Clinique
75. Uncomplicated Cystitis in an Adult Male Following Influenza B Virus Infection
    Robert Johnson Allen, Marios Koutsakos, Aeron C. Hurt, Katherine Kedzierska · 2017 · American Journal of Case Reports
76. Klinische Präsentation der Influenza beim Erwachsenen
    T. Schaberg · 2009 · Elsevier eBooks
77. Eukaryotic Virus Interactions with Bacteria: Implications for Pathogenesis and Control
    Melissa K. Jones, Erin A. Almand, Anand Soorneedi, Matthew D. Moore · 2022 · Advances in environmental microbiology
78. Reply to Reichert and Christensen
    Cecile G. Viboud, Rebecca F. Grais, Bernard A. P. Lafont, Mark A. Miller, Norio Sugaya, Lone Simonsen, Multinational Influenza Seasonal Mortality Study · 2005 · The Journal of Infectious Diseases
79. Immunodeficiency due to congenital, metabolic, infectious, surgical and environmental factors
    Javier Chinen, William T. Shearer · 2008 · Elsevier eBooks
80. Infections respiratoires à staphylocoques
    Groupe Ecrir · 2008
81. Pathogenic Characteristics of an Infection with Canine Influenza Virus and Streptococcus equi subsp. zooepidemicus Alone or in Combination in Mice
    Dan Zhao, Yaru Sun, Jingjing Guo, Yuping Tang, Zhibo Wang, Xia Wen, Yuhao Dong, Yongjie Liu · 2024 · Transboundary and Emerging Diseases
82. A sneak peak into the neurologic complications associated with H1N1 influenza
    Satish Agadi, James John Riviello, Siresha Chaluvadi · 2015 · Journal of Pediatric Neurology
83. When treating rheumatoid arthritis be vigilant for influenza (& pneumonia)
    Arvind Chopra, Vaijayanti Lagoo Joshi · 2017 · The Indian Journal of Medical Research
84. ROLE OF VIRAL AND HOST FACTORS IN INFLUENZA VIRUS MEDIATED INHIBITION OF INTERLEUKIN-23
    Ashish Tiwari · 2014
85. Antibiotic Use During an Influenza Pandemic: Downstream Ecological Effects and Antibiotic Resistance
    Andrew C. Singer, Heike Schmitt · 2011
86. Concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza--author's response
    Hong Zhang · 2008 · Journal of Antimicrobial Chemotherapy
87. Interactions of pseudorabies virus and swine influenza virus with porcine respiratory mucus
    Xiaoyun Yang · 2015 · Ghent University Academic Bibliography (Ghent University)
88. Two-photon excitation fluorometry in detection of infectious diseases
    Janne O. Koskinen · 2008 · UTUPub (University of Turku)
89. Radiologic Review of an Outbreak of the Pandemic (H1N1) 2009 Virus Infection at a University Hospital in Seoul, Korea
    Seung-hee Choi, Eun Young Kang, Jang Su Kim, Yoon Kyung Kim, Ok Hee Woo, Hwan Seok Yong, Yu‐Whan Oh · 2011 · Journal of the Korean Society of Radiology
90. Antibiotikatherapie bei Exazerbation
    Klaus Dalhoff, Henning Kothe · 2006 · Der Internist
91. Multivalent sialic acid binding proteins as novel therapeutics for influenza and parainfluenza infection
    Nadiawati Alias · 2014 · UPT. Syiah Kuala University Library (Syiah Kuala University)
92. Antibiotic Resistance and Community-Acquired Pneumonia during an Influenza Pandemic
    Matthew R. Moore, Cynthia G. Whitney · 2010 · Issues in infectious diseases
93. Ecology of virulence genes in the human pathogen Streptococcus pneumoniae
    Calum Johnston · 2008 · Enlighten: Theses (The University of Glasgow)
94. Mortalidad pediátrica asociada con la gripe en Estados Unidos: aumento de la coinfección por Staphylococcus aureus
    Lyn Finelli, Anthony E. Fiore, Rosaline Dhara, Lynnette Brammer, David K. Shay, Laurie Kamimoto, Alicia M. Fry, Jeffrey C. Hageman, Rachel J. Gorwitz, Joseph Bresee et al. · 2008 · PEDIATRICS
95. Impacto del neumococo y de los virus influenza en niños y adultos : su prevención con vacunas
    María Hortal · 2015 · DOAJ (DOAJ: Directory of Open Access Journals)
96. Infection with H274Y-positive influenza A (H1N1) is not associated with a change in nasopharyngeal Streptococcus pneumoniae colonization in patients
    Alireza Eshaghi, Joanne Blair, Laura Burton, Kam Wing Choi, Cedric De Lima, Allison McGeer, Donald E. Low, Tony Mazzulli, Steven J. Drews · 2009 · International Journal of Infectious Diseases
97. Six Adult Cases of Respiratory Complications Caused by Pandemic 2009 Influenza A (H1N1) Compared to Seasonal Influenza
    Yu Mikami, Haruyuki Ariga, Nobuharu Ohshima, Hideaki Nagai · 2011 · Kansenshogaku zasshi
98. The Comparison of Substrate Stability in Neuraminidase Type 2 (N2) Active Site between A/Tokyo/3/67 and A/Pennsylvania/10218/84 with Heating Dynamics Simulation
    Sigit Jaya Herlambang, Rosari Saleh · 2011 · World Journal of Condensed Matter Physics
99. Contributions of pneumococcal virulence factors to secondary Streptococcus pneumoniae infection following influenza infection
    Quinton O. King · 2009 · Montana State University ScholarWorks (Montana State University)
100. Effects of a primary influenza infection on susceptibility to a secondary Streptococcus pneumoniae infection
     Lynnelle A. McNamee · 2006 · Montana State University ScholarWorks (Montana State University)